The present invention relates to novel therapeutic and diagnostic
dendrimer based modular platforms (e.g.,
drug delivery platforms). In particular, the
dendrimer based modular platforms are configured such that two or more dendrimers (e.g.,
PAMAM dendrimers) are coupled together (e.g., via a
cycloaddition reaction) wherein each of the coupled dendrimers is functionalized (e.g., functionalized for targeting, imaging, sensing, and / or providing a therapeutic or diagnostic material and / or monitoring
response to therapy). In some embodiments, the present invention provides
dendrimer based modular platforms having coupled dendrimers (e.g., two or more coupled dendrimers) wherein each dendrimer is conjugated to one or more functional groups (e.g., therapeutic agent,
imaging agent, targeting agent, triggering agent) (e.g., for specific targeting and / or therapeutic use of the dendrimer based modular platform). In some embodiments, the functional groups are conjugated to the dendrimers via a
linker and / or a triggering agent. In addition, the present invention is directed to methods of synthesizing dendrimer based modular platforms, compositions comprising the dendrimer based modular platforms, as well as systems and methods utilizing the dendrimer based modular platforms (e.g., in diagnostic and / or therapeutic settings (e.g., for the delivery of therapeutics, imaging, and / or targeting agents (e.g., in
disease (e.g.,
cancer) diagnosis and / or therapy, etc.)).